| Year |
Citation |
Score |
| 2013 |
El-Kordi A, Winkler D, Hammerschmidt K, Kästner A, Krueger D, Ronnenberg A, Ritter C, Jatho J, Radyushkin K, Bourgeron T, Fischer J, Brose N, Ehrenreich H. Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behavioural Brain Research. 251: 41-9. PMID 23183221 DOI: 10.1016/J.Bbr.2012.11.016 |
0.303 |
|
| 2011 |
Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proceedings of the National Academy of Sciences of the United States of America. 108: 2587-92. PMID 21262808 DOI: 10.1073/Pnas.1013855108 |
0.336 |
|
| 2009 |
Krueger DD, Howell JL, Oo H, Olausson P, Taylor JR, Nairn AC. Prior chronic cocaine exposure in mice induces persistent alterations in cognitive function. Behavioural Pharmacology. 20: 695-704. PMID 19901826 DOI: 10.1097/FBP.0b013e328333a2bb |
0.396 |
|
| 2007 |
Krueger DD, Nairn AC. Expression of PKC substrate proteins, GAP-43 and neurogranin, is downregulated by cAMP signaling and alterations in synaptic activity. The European Journal of Neuroscience. 26: 3043-53. PMID 18005072 DOI: 10.1111/j.1460-9568.2007.05901.x |
0.411 |
|
| 2007 |
Olausson P, Jentsch JD, Krueger DD, Tronson NC, Nairn AC, Taylor JR. Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate. Annals of the New York Academy of Sciences. 1121: 610-38. PMID 17698993 DOI: 10.1196/annals.1401.016 |
0.406 |
|
| 2007 |
Andrade EC, Krueger DD, Nairn AC. Recent advances in neuroproteomics. Current Opinion in Molecular Therapeutics. 9: 270-81. PMID 17608026 |
0.412 |
|
| 2006 |
Krueger DD, Howell JL, Hebert BF, Olausson P, Taylor JR, Nairn AC. Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology. 189: 95-104. PMID 16977475 DOI: 10.1007/s00213-006-0530-0 |
0.384 |
|
| Show low-probability matches. |